Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for pustulosis palmaris et plantaris has been reported in the published literature.
8 clinical trials registered, 6 recruiting. Interventions under study include drug therapy, other interventions, and procedural interventions. Pipeline includes 1 PHASE4, 2 PHASE3, 1 PHASE2. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT07013201](https://clinicaltrials.gov/study/NCT07013201) |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 7:30 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis |
PHASE2 |
LEO Pharma |
RECRUITING |
[NCT07270003](https://clinicaltrials.gov/study/NCT07270003) | A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar Pustulosis | NA | Xijing Hospital | RECRUITING |
[NCT05994976](https://clinicaltrials.gov/study/NCT05994976) | Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers | — | Innovaderm Research Inc. | RECRUITING |
[NCT06790940](https://clinicaltrials.gov/study/NCT06790940) | Construction of a Psoriasis and Psoriatic Arthritis Diagnostic Model Based on Multidimensional Nail Information | — | Shanghai Yueyang Integrated Medicine Hospital | NOT_YET_RECRUITING |
[NCT07219420](https://clinicaltrials.gov/study/NCT07219420) | A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis | PHASE3 | UCB Biopharma SRL | RECRUITING |
141 publications have been identified in PubMed for pustulosis palmaris et plantaris. Research spans Case Report / Case Series (21%), Epidemiology / Natural History (20%), and Review / Meta-Analysis (18%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 29 | 21% |
Disease patterns and progression | 28 | 20% |
Research summaries | 26 | 18% |
Clinical study results | 24 | 17% |
Other research | 15 | 11% |
Laboratory research | 9 | 6% |
Testing and diagnosis research | 5 | 4% |
New treatment approaches | 5 | 4% |
Takahashi Y (2026). [PMID: 41670195](https://pubmed.ncbi.nlm.nih.gov/41670195/). *J Dermatol*. [Epidemiology / Natural History]
Mai SZ (2026). [PMID: 41549598](https://pubmed.ncbi.nlm.nih.gov/41549598/). *J Dtsch Dermatol Ges*. [Case Report / Case Series]
Preuß SL (2026). [PMID: 41508833](https://pubmed.ncbi.nlm.nih.gov/41508833/). *Acta dermato-venereologica*. [Epidemiology / Natural History]
Ramessur R (2026). [PMID: 41552704](https://pubmed.ncbi.nlm.nih.gov/41552704/). *JAAD international*. [Epidemiology / Natural History]
Shayegan L (2026). [PMID: 41534045](https://pubmed.ncbi.nlm.nih.gov/41534045/). *The New England journal of medicine*. [Clinical Trial Publication]
Delmotte A (2026). [PMID: 41713591](https://pubmed.ncbi.nlm.nih.gov/41713591/). *J Am Acad Dermatol*. [Epidemiology / Natural History]
Gupta AK (2026). [PMID: 41752798](https://pubmed.ncbi.nlm.nih.gov/41752798/). *Medicina (Kaunas, Lithuania)*. [Case Report / Case Series]
Ansari MS (2026). [PMID: 41953903](https://pubmed.ncbi.nlm.nih.gov/41953903/). *Health Sci Rep*. [Review / Meta-Analysis]
Akbaş A (2026). [PMID: 41942412](https://pubmed.ncbi.nlm.nih.gov/41942412/). *Eurasian J Med*. [Epidemiology / Natural History]
Cheng D (2026). [PMID: 41499108](https://pubmed.ncbi.nlm.nih.gov/41499108/). *JAMA dermatology*. [Review / Meta-Analysis]